{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"columns":[{"gene":"","key":"MONDO:0010557/OMIM:303100","label":"Choroideremia","mondoId":"MONDO:0010557","onsetQualifier":null,"recordKeys":["0098aa59ea0a9503174ce719b37a675fa1b7cc14220ccbee141da9eac4547748","210f36531749c4eb546a2def7a43ba2d05aceefb95e659fb9f3372b59e4e9931","2336ddb38b690d7b951c51a4ad06803a82caba5aea9b6240bbc1fc33d7d1ac9b","3f056d4478905dd65516a4fbc59d795be6af34f40d5637b05dfd5f593710be97","8f7ec3f06a88955c9ba7b6dfb77e3dc6753b4075f5f62179791c3b4bfa10e9c2","ac3d96745fad2ce41fb046b7ed05ac47b39193004e86f9758595bae75e3642ad","bbaac5e80512f2596b30ab6b9a73abea5e9f3a428c5d094d6b256bd02c63ec20","c3fd6b0dea864d65bd8268d9c15d134d62671d926ad0b71330d7de3282ad9fc6","c7b3bafefc779859a4677b1ddb7e55c948ca418d8fec941b487a4752c44ccb2a","cdc539cd1ae93361faceef47700e792802d5dbd93dd495b1665fd2599066a6af","d3cd5bf39bff0c031cda5842737ebf6f1a1cb4bf533fe6f46ac2fed468e610ba","e9d8a704317e7a4f8bb9308c65e1260d7e074739a2ef2fcebcc1e3953f6e11f7","f18901f49d76cb9fcc5edfe59142a08717b2c7cfa388432f2465514f32df64d1"],"recordQualifiers":{},"scopeLabel":"OMIM:303100","sourceIds":["OMIM:303100"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."},{"gene":"","key":"MONDO:0010557/ORPHA:180","label":"Choroideremia","mondoId":"MONDO:0010557","onsetQualifier":null,"recordKeys":["188fde0f59df6223730081bf9e4591d90b1de958447d866d8c7f92d4bfc37605","1c68a757a2ba79c593045721462f217cff79876166061a60aaafcfb312ac5179","31003e0bc619d36ea63ced2bc56a76564160b808700d982603f08b3a0fa750ee","36212ddc8645454ca37563ad74036a892072fbe84b2e5bf76fbfda081c5ca05b","36ac85336017e9ed05a0e12b668d4f2a190bede48aa6400154e2cb7dd43e7d4a","37116d769ee10b2d598dac5c8a8fe69e28296c173572056164edcf6728775653","3fd58b2b8dab46778d127ecb0698798ac6d3a80d2f01eeecc954f1ae66807c71","4412a332da8a8189d197d3fc092bf64812a747320ae03c9bc2e547802fd100f1","48b47a524a3a2038d22eaa0103838908c3dddefaa872eee3f922c6bf375532e1","494d800d6f0bed0d218d70bdc4ef3cd8f7f8c2bb293cfb7a7e85030f14108663","7b1fb5db12591fa9f435bec9f21dc32a35893dbe039e3aa72e49e0a6a5b74b50","91fcbd9e87f060faac1bfb2ab4a4dd1bb1742707a4dd1227e94ca1aec2aacf7b","9469dccefa59886864a94b8a6450cf69aa9e214258396209502c4d50dc6332f1","9b0b7b55b8f3781584ab89a5a5b87068103c7e6feb5f00b0c81c3b6dead46dff","9e66d950108abe63c2ebe86737dcbf0805b0a0d780d9791bc993375982791d9d"],"recordQualifiers":{},"scopeLabel":"ORPHA:180","sourceIds":["ORPHA:180"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show initial comparisons","defaultColumnKeys":["MONDO:0010557/OMIM:303100","MONDO:0010557/ORPHA:180"],"expandColumnsLabel":"Compare all source entries","intro":"Compare the original source entries. Different entries may describe different patient groups.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column keeps its native condition scope. Initial features are displayed alphabetically, not ranked by clinical importance. Counts remain separate, and an empty cell does not mean a feature cannot occur.</p>"},"coverage":{"countRecords":12,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":28,"sourceGroups":{"omim":0,"orphanet":15,"published":13}},"features":[{"hpoId":"HP:0000512","label":"Abnormal electroretinogram","primary":false},{"hpoId":"HP:0030602","label":"Abnormal fundus autofluorescence imaging","primary":false},{"hpoId":"HP:0007703","label":"Abnormal retinal pigmentation","primary":false},{"hpoId":"HP:0007843","label":"Attenuation of retinal blood vessels","primary":false},{"hpoId":"HP:0000533","label":"Chorioretinal atrophy","primary":false},{"hpoId":"HP:0001139","label":"Chorioretinal scalloped atrophy","primary":false},{"hpoId":"HP:0011506","label":"Choroidal neovascularization","primary":false},{"hpoId":"HP:0000551","label":"Color vision defect","primary":false},{"hpoId":"HP:0001133","label":"Constriction of peripheral visual field","primary":false},{"hpoId":"HP:0007894","label":"Fundus hypopigmentation","primary":false},{"hpoId":"HP:0007793","label":"Granular macular appearance","primary":false},{"hpoId":"HP:0040049","label":"Macular edema","primary":false},{"hpoId":"HP:0000545","label":"Nearsightedness","primary":false},{"hpoId":"HP:0030505","label":"Nummular pigmentation of the retina","primary":false},{"hpoId":"HP:0000662","label":"Nyctalopia","primary":false},{"hpoId":"HP:0007994","label":"Peripheral visual field loss","primary":false},{"hpoId":"HP:0000580","label":"Pigmentary retinopathy","primary":false},{"hpoId":"HP:0007787","label":"Posterior subcapsular cataract","primary":false},{"hpoId":"HP:0000529","label":"Progressive vision loss","primary":false},{"hpoId":"HP:0007814","label":"Retinal pigment epithelial mottling","primary":false},{"hpoId":"HP:0007737","label":"Spicular pigmentation of the retina","primary":false},{"hpoId":"HP:0000505","label":"Visual impairment","primary":false}],"ledeHtml":"Choroideremia is a condition characterized by progressive vision loss that mainly affects males. The first symptom of this condition is usually an impairment of night vision (night blindness), which can occur in early childhood. A progressive narrowing of the field of vision (tunnel vision) follows, as well as a decrease in the ability to see details (visual acuity). These vision problems are due to an ongoing loss of cells (atrophy) in the specialized light-sensitive tissue that lines the back of the eye (retina) and a nearby network of blood vessels (the choroid). The vision impairment in choroideremia worsens over time, but the progression varies among affected individuals. However, all individuals with this condition will develop blindness, most commonly in late adulthood.","mondoId":"MONDO:0010557","records":[{"frequencyKind":"count","key":"0098aa59ea0a9503174ce719b37a675fa1b7cc14220ccbee141da9eac4547748","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:303100","disease_name":"Choroideremia","evidence":"PCS","frequency_raw":"4/4","hpo_id":"HP:0007894","is_excluded":false,"label":"Fundus hypopigmentation","onset_id":null,"reference":"PMID:17698759","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"188fde0f59df6223730081bf9e4591d90b1de958447d866d8c7f92d4bfc37605","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:180","disease_name":"Choroideremia","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000545","is_excluded":false,"label":"Myopia","onset_id":null,"reference":"ORPHA:180","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"1c68a757a2ba79c593045721462f217cff79876166061a60aaafcfb312ac5179","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:180","disease_name":"Choroideremia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0040049","is_excluded":false,"label":"Macular edema","onset_id":null,"reference":"ORPHA:180","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"210f36531749c4eb546a2def7a43ba2d05aceefb95e659fb9f3372b59e4e9931","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:303100","disease_name":"Choroideremia","evidence":"PCS","frequency_raw":"3/3","hpo_id":"HP:0000529","is_excluded":false,"label":"Progressive visual loss","onset_id":"HP:0003596","reference":"PMID:17698759","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"2336ddb38b690d7b951c51a4ad06803a82caba5aea9b6240bbc1fc33d7d1ac9b","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:303100","disease_name":"Choroideremia","evidence":"PCS","frequency_raw":"10/10","hpo_id":"HP:0000505","is_excluded":false,"label":"Visual impairment","onset_id":null,"reference":"PMID:17698759;PMID:24913019","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"31003e0bc619d36ea63ced2bc56a76564160b808700d982603f08b3a0fa750ee","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:180","disease_name":"Choroideremia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001133","is_excluded":false,"label":"Constriction of peripheral visual field","onset_id":null,"reference":"ORPHA:180","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"36212ddc8645454ca37563ad74036a892072fbe84b2e5bf76fbfda081c5ca05b","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:180","disease_name":"Choroideremia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000533","is_excluded":false,"label":"Chorioretinal atrophy","onset_id":null,"reference":"ORPHA:180","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"36ac85336017e9ed05a0e12b668d4f2a190bede48aa6400154e2cb7dd43e7d4a","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:180","disease_name":"Choroideremia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000529","is_excluded":false,"label":"Progressive visual loss","onset_id":null,"reference":"ORPHA:180","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"37116d769ee10b2d598dac5c8a8fe69e28296c173572056164edcf6728775653","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:180","disease_name":"Choroideremia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0011506","is_excluded":false,"label":"Choroidal neovascularization","onset_id":null,"reference":"ORPHA:180","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"3f056d4478905dd65516a4fbc59d795be6af34f40d5637b05dfd5f593710be97","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:303100","disease_name":"Choroideremia","evidence":"PCS","frequency_raw":"3/6","hpo_id":"HP:0007737","is_excluded":false,"label":"Spicular pigmentation of the retina","onset_id":null,"reference":"PMID:24913019","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"3fd58b2b8dab46778d127ecb0698798ac6d3a80d2f01eeecc954f1ae66807c71","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:180","disease_name":"Choroideremia","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000505","is_excluded":false,"label":"Visual impairment","onset_id":null,"reference":"ORPHA:180","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4412a332da8a8189d197d3fc092bf64812a747320ae03c9bc2e547802fd100f1","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:180","disease_name":"Choroideremia","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0007703","is_excluded":false,"label":"Abnormal retinal pigmentation","onset_id":null,"reference":"ORPHA:180","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"48b47a524a3a2038d22eaa0103838908c3dddefaa872eee3f922c6bf375532e1","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:180","disease_name":"Choroideremia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001139","is_excluded":false,"label":"Chorioretinal scalloped atrophy","onset_id":null,"reference":"ORPHA:180","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"494d800d6f0bed0d218d70bdc4ef3cd8f7f8c2bb293cfb7a7e85030f14108663","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:180","disease_name":"Choroideremia","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000512","is_excluded":false,"label":"Abnormal electroretinogram","onset_id":null,"reference":"ORPHA:180","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"7b1fb5db12591fa9f435bec9f21dc32a35893dbe039e3aa72e49e0a6a5b74b50","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:180","disease_name":"Choroideremia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000551","is_excluded":false,"label":"Color vision defect","onset_id":null,"reference":"ORPHA:180","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"8f7ec3f06a88955c9ba7b6dfb77e3dc6753b4075f5f62179791c3b4bfa10e9c2","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:303100","disease_name":"Choroideremia","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0001139","is_excluded":false,"label":"Chorioretinal scalloped atrophy","onset_id":null,"reference":"PMID:17698759","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"91fcbd9e87f060faac1bfb2ab4a4dd1bb1742707a4dd1227e94ca1aec2aacf7b","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:180","disease_name":"Choroideremia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0030602","is_excluded":false,"label":"Abnormal fundus autofluorescence imaging","onset_id":null,"reference":"ORPHA:180","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9469dccefa59886864a94b8a6450cf69aa9e214258396209502c4d50dc6332f1","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:180","disease_name":"Choroideremia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0007994","is_excluded":false,"label":"Peripheral visual field loss","onset_id":null,"reference":"ORPHA:180","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9b0b7b55b8f3781584ab89a5a5b87068103c7e6feb5f00b0c81c3b6dead46dff","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:180","disease_name":"Choroideremia","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000662","is_excluded":false,"label":"Nyctalopia","onset_id":null,"reference":"ORPHA:180","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9e66d950108abe63c2ebe86737dcbf0805b0a0d780d9791bc993375982791d9d","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:180","disease_name":"Choroideremia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0007787","is_excluded":false,"label":"Posterior subcapsular cataract","onset_id":null,"reference":"ORPHA:180","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"ac3d96745fad2ce41fb046b7ed05ac47b39193004e86f9758595bae75e3642ad","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:303100","disease_name":"Choroideremia","evidence":"PCS","frequency_raw":"1/4","hpo_id":"HP:0007793","is_excluded":false,"label":"Granular macular appearance","onset_id":null,"reference":"PMID:17698759","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"bbaac5e80512f2596b30ab6b9a73abea5e9f3a428c5d094d6b256bd02c63ec20","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:303100","disease_name":"Choroideremia","evidence":"PCS","frequency_raw":"20/20","hpo_id":"HP:0000533","is_excluded":false,"label":"Chorioretinal atrophy","onset_id":null,"reference":"PMID:17698759","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"c3fd6b0dea864d65bd8268d9c15d134d62671d926ad0b71330d7de3282ad9fc6","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:303100","disease_name":"Choroideremia","evidence":"PCS","frequency_raw":"4/4","hpo_id":"HP:0000580","is_excluded":false,"label":"Pigmentary retinopathy","onset_id":null,"reference":"PMID:17698759","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"c7b3bafefc779859a4677b1ddb7e55c948ca418d8fec941b487a4752c44ccb2a","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:303100","disease_name":"Choroideremia","evidence":"PCS","frequency_raw":"10/10","hpo_id":"HP:0000662","is_excluded":false,"label":"Nyctalopia","onset_id":null,"reference":"PMID:17698759;PMID:24913019","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"cdc539cd1ae93361faceef47700e792802d5dbd93dd495b1665fd2599066a6af","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:303100","disease_name":"Choroideremia","evidence":"PCS","frequency_raw":"1/4","hpo_id":"HP:0030505","is_excluded":false,"label":"Nummular pigmentation of the retina","onset_id":null,"reference":"PMID:17698759","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"d3cd5bf39bff0c031cda5842737ebf6f1a1cb4bf533fe6f46ac2fed468e610ba","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:303100","disease_name":"Choroideremia","evidence":"PCS","frequency_raw":"3/3","hpo_id":"HP:0001133","is_excluded":false,"label":"Constriction of peripheral visual field","onset_id":"HP:0003596","reference":"PMID:17698759","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"e9d8a704317e7a4f8bb9308c65e1260d7e074739a2ef2fcebcc1e3953f6e11f7","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:303100","disease_name":"Choroideremia","evidence":"PCS","frequency_raw":"4/6","hpo_id":"HP:0007843","is_excluded":false,"label":"Attenuation of retinal blood vessels","onset_id":null,"reference":"PMID:24913019","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"f18901f49d76cb9fcc5edfe59142a08717b2c7cfa388432f2465514f32df64d1","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:303100","disease_name":"Choroideremia","evidence":"PCS","frequency_raw":"1/6","hpo_id":"HP:0007814","is_excluded":false,"label":"Retinal pigment epithelial mottling","onset_id":null,"reference":"PMID:24913019","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<ul><li><a href=\"https://medlineplus.gov/genetics/condition/choroideremia\">Choroideremia</a></li></ul>","identityNote":"MONDO cross-references identify native condition entries. Ancestor membership does not transfer phenotype values between groups.","importantHtml":""},"sections":[{"bodyHtml":"<p>Mutations in the CHM gene cause choroideremia. The CHM gene provides instructions for producing the Rab escort protein-1 (REP-1). As an escort protein, REP-1 attaches to molecules called Rab proteins within the cell and directs them to the membranes of various cell compartments (organelles). Rab proteins are involved in the movement of proteins and organelles within cells (intracellular trafficking). Mutations in the CHM gene lead to an absence of REP-1 protein or the production of a REP-1 protein that cannot carry out its protein escort function. This lack of functional REP-1 prevents Rab proteins from reaching and attaching (binding) to the organelle membranes. Without the aid of Rab proteins in intracellular trafficking, cells die prematurely.</p><p>The REP-1 protein is active (expressed) throughout the body, as is a similar protein, REP-2. Research suggests that when REP-1 is absent or nonfunctional, REP-2 can perform the protein escort duties of REP-1 in many of the body&#x27;s tissues. Very little REP-2 protein is present in the retina, however, so it cannot compensate for the loss of REP-1 in this tissue. Loss of REP-1 function and subsequent misplacement of Rab proteins within the cells of the retina causes the progressive vision loss characteristic of choroideremia.</p><p class=\"section-source\"><a href=\"https://medlineplus.gov/genetics/condition/choroideremia/#causes\">MedlinePlus Genetics: Causes</a></p>","key":"forms","title":"What causes Choroideremia?"},{"bodyHtml":"<p class=\"section-source\">Source: <a href=\"https://medlineplus.gov/genetics/condition/choroideremia\">MedlinePlus Genetics</a></p>","key":"overview","title":"Condition overview"}],"sharedSources":[],"slug":"choroideremia","sourceDocuments":[{"name":"Choroideremia","reviewed":"2008-07","sections":{"causes":{"fetchedAt":"2026-10-20T20:20:16.593774+00:00","label":"Causes","pageSha256":"115eb6f50d4029b5cfb7bbaf64af8bfdfe8023e4a3c0ef5061be3e3481186e33","sourceUrl":"https://medlineplus.gov/genetics/condition/choroideremia/#causes","status":"available"}},"source_release":"2026-10-01","url":"https://medlineplus.gov/genetics/condition/choroideremia"}],"sourceNote":"MedlinePlus descriptions and Causes; original HPO annotations.","takeawayHtml":"Cause explanations are from MedlinePlus Genetics. Feature values below retain their original sources and patient groups.","title":"Choroideremia"},"schemaVersion":1}